Literature DB >> 12324914

Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation.

Marta Todeschini1, Daniela Macconi, Nuria García Fernández, Marina Ghilardi, Agostina Anabaya, Elena Binda, Marina Morigi, Dario Cattaneo, Elena Perticucci, Giuseppe Remuzzi, Marina Noris.   

Abstract

BACKGROUND: Activation of polymorphonuclear neutrophils (PMNs) and monocytes has been described during hemodialysis (HD), which results in the release of reactive oxygen species and cytokines. Acetate-free biofiltration (AFB) has been shown to cause less monocyte activation and cytokine release than bicarbonate HD (BHD). No data are available to date on the effect of AFB on PMN activation.
METHODS: We studied ex vivo superoxide anion release by PMNs isolated from nine patients treated in random order with AFB or BHD (three sessions each). Plasma interleukin-1beta (IL-1beta) levels and the nitric oxide (NO) synthetic pathway also were evaluated. A polyacrylonitrile (AN69; Hospal, Bologna, Italy) dialyzer was used for both treatments. Fourteen healthy volunteers were used as controls. Blood samples were drawn predialysis and 5 and 15 minutes after starting dialysis to obtain plasma and PMNs.
RESULTS: Neither ex vivo superoxide anion release nor blood PMN count was affected by AFB. Conversely, a peak in superoxide anion production associated with a decrease in PMN count was observed at 5 minutes during BHD. Results of superoxide anion production by control PMNs exposed in vitro to AFB or bicarbonate dialysis bath or Hank's balanced salt solution supplemented with bicarbonate or acetate indicated that BHD-induced PMN activation could be attributed to the amount of bicarbonate present in the dialysis bath. IL-1beta plasma levels did not change during dialysis with AFB and were numerically higher at 5 and 15 minutes with respect to predialysis values during BHD. Uremic plasma obtained during either AFB or BHD induced greater NO synthesis by human umbilical vein endothelial cells than control plasma.
CONCLUSION: AFB, unlike BHD, does not cause PMN and monocyte activation, which could have a positive impact on dialysis-associated cardiovascular disease of dialyzed patients. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12324914     DOI: 10.1053/ajkd.2002.35690

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

1.  Increased efficiency of hemodialysis with citrate dialysate: a prospective controlled study.

Authors:  Robert J Kossmann; Annette Gonzales; Robin Callan; Suhail Ahmad
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-06       Impact factor: 8.237

2.  Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study "Hephaestus".

Authors:  Francesco Pizzarelli; Vincenzo Cantaluppi; Vincenzo Panichi; Alessandro Toccafondi; Giuseppe Ferro; Serena Farruggio; Elena Grossini; Pietro Claudio Dattolo; Vincenzo Miniello; Massimiliano Migliori; Cristina Grimaldi; Aldo Casani; Maurizio Borzumati; Stefano Cusinato; Alessandro Capitanini; Alessandro Quercia; Oliviero Filiberti; Lucia Dani
Journal:  J Nephrol       Date:  2021-02-09       Impact factor: 3.902

3.  Acetate-free blood purification can impact improved nutritional status in hemodialysis patients.

Authors:  Kazuhiro Matsuyama; Tadashi Tomo; Jun-ichi Kadota
Journal:  J Artif Organs       Date:  2011-02-19       Impact factor: 1.731

4.  Identification and characterization of circulating variants of CXCL12 from human plasma: effects on chemotaxis and mobilization of hematopoietic stem and progenitor cells.

Authors:  Rudolf Richter; Andrea Jochheim-Richter; Felicia Ciuculescu; Katarina Kollar; Erhard Seifried; Ulf Forssmann; Dennis Verzijl; Martine J Smit; Xavier Blanchet; Philipp von Hundelshausen; Christian Weber; Wolf-Georg Forssmann; Reinhard Henschler
Journal:  Stem Cells Dev       Date:  2014-05-27       Impact factor: 3.272

Review 5.  Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

Authors:  A M Macleod; M Campbell; J D Cody; C Daly; C Donaldson; A Grant; I Khan; K S Rabindranath; L Vale; S Wallace
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

6.  Conversion from acetate dialysate to citrate dialysate in a central delivery system for maintenance hemodialysis patients.

Authors:  Eun Ji Park; Su Woong Jung; Da Rae Kim; Jin Sug Kim; Tae Won Lee; Chun Gyoo Ihm; Kyung Hwan Jeong
Journal:  Kidney Res Clin Pract       Date:  2019-03-31

7.  Effects of acetate-free citrate dialysate on glycoxidation and lipid peroxidation products in hemodialysis patients.

Authors:  Atsumi Masuda; Shinji Hagiwara; Mitsuo Tanimoto; Fumiko Kodama; Kozue Okumura; Nao Nohara; Mayumi Matsumoto; Masayuki Maiguma; Keisuke Omote; Hiroaki Io; Atsushi Kurusu; Isao Ohsawa; Yoshio Shimizu; Chieko Hamada; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Nephron Extra       Date:  2012-09-27

8.  Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH.

Authors:  Takahiro Kuragano; Minoru Furuta; Mana Yahiro; Aritoshi Kida; Yoshinaga Otaki; Yukiko Hasuike; Akihide Matsumoto; Takeshi Nakanishi
Journal:  BMC Nephrol       Date:  2013-01-18       Impact factor: 2.388

9.  Post-dilution on line haemodiafiltration with citrate dialysate: first clinical experience in chronic dialysis patients.

Authors:  Vincenzo Panichi; Enrico Fiaccadori; Alberto Rosati; Roberto Fanelli; Giada Bernabini; Alessia Scatena; Francesco Pizzarelli
Journal:  ScientificWorldJournal       Date:  2013-12-03

10.  Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility.

Authors:  Gunilla Grundström; Anders Christensson; Maria Alquist; Lars-Göran Nilsson; Mårten Segelmark
Journal:  BMC Nephrol       Date:  2013-10-09       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.